Moderna | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 243.83M 19.91M 2025-06
Adcock Ingram Holdings ZAR 1.54B 73.26M 2024-12
Agios Pharmaceuticals USD 10.75M 3.11M 2025-06
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Amgen USD 6.17B 624M 2025-06
Arrowhead Research 27.77M 514.94M 2025-06
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Celltrion KRW 442.87B 100.93B 2025-03
Cspc Pharmaceutical CNY 4.71B 391.66M 2025-03
Dianthus Therapeutics 1.16M 164K 2025-03
Divis Laboratories Ltd 14.54B 1.5B 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
Incyte USD 1.14B 151.67M 2025-06
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
Kangmei Pharma CNY 223.73M 38.54M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Moderna USD 18M 1000K 2025-06
Organigram Holdings CAD 1.05M 67.34M 2024-12
Pharma Mar EUR 53.61M 18.15M 2025-06
Qiagen NV USD 334.29M 25.6M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Sarepta Therapeutics USD 457.87M 149.43M 2025-06
Sartorius EUR 416.2M 14.8M 2025-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tilray USD 61.22M 1.51M 2024-11
Ultragenyx Pharmaceutical USD 143.49M 32.86M 2025-06
United Therapeutics USD 711M 9.1M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06
Zz Pientze Pharmaceu 1.39B 632.84M 2025-03


Moderna Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.